KR0127137B1 - 디데옥시디데히드로카르보시클릭 뉴클레오시드 - Google Patents

디데옥시디데히드로카르보시클릭 뉴클레오시드

Info

Publication number
KR0127137B1
KR0127137B1 KR1019890000551A KR890000551A KR0127137B1 KR 0127137 B1 KR0127137 B1 KR 0127137B1 KR 1019890000551 A KR1019890000551 A KR 1019890000551A KR 890000551 A KR890000551 A KR 890000551A KR 0127137 B1 KR0127137 B1 KR 0127137B1
Authority
KR
South Korea
Prior art keywords
compound
purin
formula
cyclopentenylcarbinol
group
Prior art date
Application number
KR1019890000551A
Other languages
English (en)
Korean (ko)
Other versions
KR890011902A (ko
Inventor
빈스 로버트
후아 메이
레슬리 마이어스 피터
스토러 리차드
Original Assignee
존. 에프. 쎈테
리전츠 오브 더 유니버시티 오브 미네소타
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/146,252 external-priority patent/US4916224A/en
Priority claimed from GB888821011A external-priority patent/GB8821011D0/en
Priority claimed from US07/278,652 external-priority patent/US4931559A/en
Application filed by 존. 에프. 쎈테, 리전츠 오브 더 유니버시티 오브 미네소타 filed Critical 존. 에프. 쎈테
Publication of KR890011902A publication Critical patent/KR890011902A/ko
Application granted granted Critical
Publication of KR0127137B1 publication Critical patent/KR0127137B1/ko

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
KR1019890000551A 1988-01-20 1989-01-19 디데옥시디데히드로카르보시클릭 뉴클레오시드 KR0127137B1 (ko)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US07/146,252 US4916224A (en) 1988-01-20 1988-01-20 Dideoxycarbocyclic nucleosides
US146,252 1988-01-20
GB888821011A GB8821011D0 (en) 1988-09-07 1988-09-07 Chemical compounds
US8821011.7 1988-12-05
US278,652 1988-12-05
US07/278,652 US4931559A (en) 1988-01-20 1988-12-05 Optically-active isomers of dideoxycarbocyclic nucleosides

Publications (2)

Publication Number Publication Date
KR890011902A KR890011902A (ko) 1989-08-23
KR0127137B1 true KR0127137B1 (ko) 1997-12-29

Family

ID=27264063

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890000551A KR0127137B1 (ko) 1988-01-20 1989-01-19 디데옥시디데히드로카르보시클릭 뉴클레오시드

Country Status (29)

Country Link
JP (1) JP2793825B2 (zh)
KR (1) KR0127137B1 (zh)
AT (1) AT397801B (zh)
AU (2) AU626278B2 (zh)
BE (1) BE1003815A4 (zh)
CA (1) CA1339896C (zh)
CH (1) CH679152A5 (zh)
DE (1) DE3901502C2 (zh)
DK (1) DK175131B1 (zh)
ES (1) ES2010091A6 (zh)
FI (1) FI93546C (zh)
FR (1) FR2626002B1 (zh)
GB (1) GB2217320B (zh)
GR (1) GR890100033A (zh)
HU (1) HU203755B (zh)
IE (1) IE62275B1 (zh)
IL (1) IL88999A (zh)
IT (1) IT1229531B (zh)
LU (1) LU87437A1 (zh)
MY (1) MY103801A (zh)
NL (1) NL8900122A (zh)
NO (1) NO169123C (zh)
NZ (1) NZ227663A (zh)
OA (1) OA09031A (zh)
PL (1) PL163814B1 (zh)
PT (1) PT89482B (zh)
RU (1) RU2114846C1 (zh)
SE (1) SE505213C2 (zh)
YU (1) YU47791B (zh)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1215339B (it) * 1987-01-14 1990-02-08 Co Pharma Corp Srl Procedimento per la preparazione di 9-(idrossialchil)-ipoxantine
US5631370A (en) 1988-01-20 1997-05-20 Regents Of The University Of Minnesota Optically-active isomers of dideoxycarbocyclic nucleosides
GB8815265D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
US4939252A (en) * 1989-04-20 1990-07-03 Hoffmann-La Roche Inc. Novel intermediates for the preparation of Carbovir
DK0479822T3 (da) * 1989-06-27 2000-03-20 Wellcome Found Terapeutiske nucleosider
GB8916478D0 (en) * 1989-07-19 1989-09-06 Glaxo Group Ltd Chemical process
GB8916479D0 (en) * 1989-07-19 1989-09-06 Glaxo Group Ltd Chemical process
GB8916477D0 (en) * 1989-07-19 1989-09-06 Glaxo Group Ltd Chemical process
GB8916480D0 (en) * 1989-07-19 1989-09-06 Glaxo Group Ltd Chemical process
MY104575A (en) * 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.
US5144034A (en) * 1990-04-06 1992-09-01 Glaxo Inc. Process for the synthesis of cyclopentene derivatives of purines
US5241069A (en) * 1990-04-06 1993-08-31 Glaxo Inc. Carbonate intermediates for the synthesis of purine substituted cyclopentene derivatives
US5057630A (en) * 1990-04-06 1991-10-15 Glaxo Inc. Synthesis of cyclopentene derivatives
US5126452A (en) * 1990-04-06 1992-06-30 Glaxo Inc. Synthesis of purine substituted cyclopentene derivatives
GB9108376D0 (en) * 1991-04-19 1991-06-05 Enzymatix Ltd Cyclopentenes
KR960705825A (ko) * 1993-11-12 1996-11-08 게리 디. 스트리트 면역억제제로서 유용한 6-옥소-뉴클레오시드(6-Oxo-nucleosides useful as immunosuppressants)
GB9721780D0 (en) * 1997-10-14 1997-12-10 Glaxo Group Ltd Process for the synthesis of chloropurine intermediates
AU1158000A (en) * 1998-10-30 2000-05-22 Lonza A.G. Method for producing 4- ((2',5'- diamino-6'- halopyrimidine- 4'-YL)amino)- cyclopent- 2-enylmethanols
US6433170B1 (en) 1998-10-30 2002-08-13 Lonza Group Method for producing 4-[2',5'-diamino-6'-halopyrimidine-4'-yl)amino]- cyclopent-2-enylmethanols
TWI229674B (en) 1998-12-04 2005-03-21 Astra Pharma Prod Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses
GB9903091D0 (en) * 1999-02-12 1999-03-31 Glaxo Group Ltd Therapeutic nucleoside compound
AR039540A1 (es) 2002-05-13 2005-02-23 Tibotec Pharm Ltd Compuestos microbicidas con contenido de pirimidina o triazina
CN112512529B (zh) 2018-07-27 2024-06-18 富士胶片株式会社 环戊烯嘌呤衍生物或其盐
WO2021191417A1 (en) 2020-03-27 2021-09-30 Som Innovation Biotech, S.A. Compounds for use in the treatment of synucleinopathies

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4268672A (en) * 1977-02-09 1981-05-19 The Regents Of The University Of Minnesota Adenosine deaminase resistant antiviral purine nucleosides and method of preparation
US4742064A (en) * 1985-09-10 1988-05-03 Regents Of The University Of Minnesota Antiviral carbocyclic analogs of xylofuranosylpurines
JPS62177234A (ja) * 1986-01-30 1987-08-04 Mitsubishi Heavy Ind Ltd 遠心紡糸によるカ−ボン繊維の製造装置
IN164556B (zh) * 1986-03-06 1989-04-08 Takeda Chemical Industries Ltd
NZ229453A (en) * 1988-06-10 1991-08-27 Univ Minnesota & Southern Rese A pharmaceutical composition containing purine derivatives with nucleosides such as azt, as antiviral agents
GB8815265D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
MY104575A (en) * 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.

Also Published As

Publication number Publication date
CA1339896C (en) 1998-06-02
DK175131B1 (da) 2004-06-14
IT1229531B (it) 1991-09-04
YU47791B (sr) 1996-01-09
IL88999A0 (en) 1989-08-15
ATA10689A (de) 1993-11-15
IT8947546A0 (it) 1989-01-19
PL163814B1 (en) 1994-05-31
NO890253D0 (no) 1989-01-19
NO890253L (no) 1989-07-21
BE1003815A4 (fr) 1992-06-23
PT89482A (pt) 1989-10-04
GR890100033A (el) 1994-03-31
GB2217320A (en) 1989-10-25
AU2867189A (en) 1989-07-20
CH679152A5 (zh) 1991-12-31
DK23489D0 (da) 1989-01-19
RU2114846C1 (ru) 1998-07-10
KR890011902A (ko) 1989-08-23
HUT48887A (en) 1989-07-28
MY103801A (en) 1993-09-30
DE3901502A1 (de) 1989-07-27
SE8900192D0 (sv) 1989-01-19
AU626278B2 (en) 1992-07-30
NO169123C (no) 1992-05-13
IE62275B1 (en) 1995-01-25
AU1018092A (en) 1992-03-12
OA09031A (en) 1991-03-31
FI890286A0 (fi) 1989-01-19
FI93546C (fi) 1995-04-25
AT397801B (de) 1994-07-25
YU12389A (en) 1991-10-31
JP2793825B2 (ja) 1998-09-03
LU87437A1 (fr) 1989-08-30
IL88999A (en) 1994-12-29
DE3901502C2 (de) 2002-06-13
GB8901187D0 (en) 1989-03-15
FR2626002A1 (fr) 1989-07-21
FR2626002B1 (fr) 1994-01-28
FI93546B (fi) 1995-01-13
HU203755B (en) 1991-09-30
GB2217320B (en) 1992-04-08
SE8900192L (sv) 1989-07-21
SE505213C2 (sv) 1997-07-14
JPH02196788A (ja) 1990-08-03
NL8900122A (nl) 1989-08-16
AU637015B2 (en) 1993-05-13
NO169123B (no) 1992-02-03
NZ227663A (en) 1990-09-26
PL277261A1 (en) 1989-09-18
DK23489A (da) 1989-07-21
FI890286A (fi) 1989-07-21
PT89482B (pt) 1994-02-28
IE890153L (en) 1989-07-20
ES2010091A6 (es) 1989-10-16

Similar Documents

Publication Publication Date Title
KR0127137B1 (ko) 디데옥시디데히드로카르보시클릭 뉴클레오시드
AP91A (en) Dideoxydidehydrocarbocyclic nucleosides.
KR0140532B1 (ko) 치료용 뉴클레오시드
US6534512B1 (en) Dideoxycarbocyclic nucleosides
CZ658390A3 (en) Enantiomeric purine derivatives, process of their preparation, pharmaceutical compositions containing thereof and their use
HU195657B (en) Process for production of carbocyclic pirin nucleorids and medical compounds containing them
JPH07116042B2 (ja) ヌクレオシド化合物
HUT70030A (en) 1,3-oxathiolane nucleoside analogues and pharmaceutical compositions containing them, and process for their preparation
JPS63297381A (ja) ９−〔２−（ヒドロキシメチル）シクロアルキルメチル〕グアニン類
AU627188B2 (en) Pharmaceutical products
EP0285432B1 (en) Therapeutic nucleosides
US10167302B2 (en) Phosphonate nucleosides useful in the treatment of viral diseases
JP3164361B2 (ja) 治療用ヌクレオシド
CN1031055C (zh) 二脱氧二脱氢碳环核苷的制备方法
EP0394346A1 (en) Pyrimidine and purine 1,2-butadiene-4-ols as anti-retroviral agents
GB2243609A (en) Carbocyclic nucleosides
SI8910123A (sl) Dideoksidihidrokarbocikličninukleozidi
JPH05178746A (ja) 抗ウイルス剤

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20111010

Year of fee payment: 15

EXPY Expiration of term